超声声像图征象与分子生物学指标在乳腺癌患者术后3年预后评估中的应用价值

doi:10.3969/j.issn.1671-7171.2024.03.004

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1331 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】 To explore the application value of breast cancer ultrasonic signs and molecular biological indicators in the prognosis evaluation of breast cancer patients 3 years after operation. 【Methods】The clinical data of 100 female breast cancer patients diagnosed and treated in our hospital from March 2017 to March 2020 were retrospectively analyzed. Cox risk regression model was used to analyze the predictive value of molecular biological indicators [estrogen receptor(ER), progesterone receptor(PR), proliferating cell nuclear antigen(Ki-67), human epidermal growth factor receptor 2(HER2), carbohydrate antigen 15-3(CA15-3), carbohydrate antigen 125(CA125)] and ultrasound signs(lymph node metastasis, tumor size, calcification, internal echo) for the prognosis of breast cancer patients after 3 years. 【Results】During the 3-year follow-up of 100 patients, 17(17.00%) patients developed local recurrence or metastasis, and 3(3.00%) patients died. Univariate COX regression analysis showed that tumor diameter, calcification, Ki-67 and pathological stage were the influencing factors of 3-year overall survival and recurrence free survival of breast cancer patients(P<0.05); Multivariate COX regression analysis showed that tumor diameter > 5.0 cm, calcification, Ki-67 ≥ 14% were the risk factors affecting the 3-year overall survival and recurrence free survival of breast cancer patients(P<0.05). 【Conclusion】Tumor diameter, calcification and Ki-67 are associated with poor prognosis in breast cancer patients.

Key words： Breast Neoplasms/SU Ultrasonography Molecular Biology Prognosis

Received: 21 May 2023

PACS:

R737.9

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WANG Shu
	YAN Jingru

Cite this article:

WANG Shu,YAN Jingru. The Application Value of Breast Cancer Ultrasonic Signs and Molecular Biological Indicators in the Prognosis Evaluation of Breast Cancer Patients 3 Years after Operation[J]. JOURNAL OF CLINICAL RESEARCH, 2024, 41(3): 332-335.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2024.03.004 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2024/V41/I3/332

[1] 张雪, 董晓平, 管雅喆,等. 女性乳腺癌流行病学趋势及危险因素研究进展[J].肿瘤防治研究, 2021, 48(1):87-92.
[2] 中国抗癌协会国际医疗与交流分会, 中国医师协会肿瘤医师分会乳腺癌学组. 晚期乳腺癌基因检测热点问题中国专家共识(2021版)[J].中华肿瘤杂志, 2022, 44(1):60-67.
[3] 陈燕, 张江宇, 王丽敏,等. 非特殊型浸润性乳腺癌超声征象与分子生物学指标关系分析[J].广东医学, 2019, 40(11):1579-1583.
[4] 黄贵廉, 陈智毅. 乳腺癌超声征象与分子标志物的相关性研究进展[J].中国医学影像学杂志, 2021, 29(1):86-88.
[5] 王宇航, 宋全福, 吴俊强,等. ER阳性乳腺癌中FGFR1蛋白的表达与ER及预后的关系[J].中国癌症杂志, 2019, 29(5):345-351.
[6] 沈吉, 韩运生, 陈文显. 乳腺癌超声弹性成像与组织学特征、分子生物学指标的相关性[J].中国老年学杂志, 2019, 39(1):72-74.
[7] 邵志敏, 江泽飞, 李俊杰,等. 中国乳腺癌新辅助治疗专家共识(2019年版)[J].中国癌症杂志, 2019,29(5):390-400.
[8] 林明曦,张剑.乳腺癌骨转移分子机制的研究进展[J].肿瘤,2019,39(9):767-774.
[9] 黄秒, 苏丹柯, 金观桥,等. 乳腺癌X线摄影表现与ER、PR和HER-2表达的相关性研究[J].实用放射学杂志, 2020, 36(2):214-218.
[10] 闫峰山, 周晶, 白岩,等. 不同Ki-67表达状态乳腺癌患者临床和DCE-MRI特征[J].中国医学影像技术, 2019, 318(11):63-68.
[11] 冯桂英,钟婷婷,杨大艳,等.超声评分法在特殊型浸润性乳腺癌诊断中的应用研究[J].中国超声医学杂志,2021,37(3):256-259.
[12] 刘斌, 范明, 厉力华. 动态增强影像特征与乳腺癌预后的关联性研究[J].传感技术学报, 2019, 32(4):580-585.
[13] 樊弘, 周礼平, 蒙荣钦. 彩色多普勒超声成像在乳腺癌诊断及化疗效果评估中的意义[J].实用癌症杂志, 2019,34(3):497-499.
[14] 李继斌,赵明增,张录林,等.乳腺癌患者MRI影像学征象与病理特征的相关性[J].医学临床研究,2021,38(10):1585-1587.
[15] 纪晓惠, 石可心, 赵倩颖,等. 高频超声对乳腺癌内乳淋巴结转移的诊断价值[J].中华超声影像学杂志, 2021, 30(1):58.
[16] 金利芳, 庄玲玲, 夏祯,等. 淋巴超声造影定性诊断乳腺癌前哨淋巴结的分型研究[J].中华超声影像学杂志, 2019, 28(11):986-989.
[17] 梁伟翔, 蒋殿虎, 陆培明. 乳腺癌高回声晕超声特征与ER、PR表达水平的相关性分析[J].医学影像学杂志, 2020, 30(6):1001-1004.
[18] 储荣先, 彭梅. 浸润性乳腺癌患者组织ER、PR及HER-2与超声影像的关系分析[J].中国超声医学杂志, 2021, 37(9):986-989.
[19] 尹志辉,周志伟,刘继勇,等. 乳腺癌患者组织多项组化标记物与血清CA153、CA125、CEA、25-OH-D₃水平关联性分析模型建立及在预后判断的临床价值[J].现代检验医学杂志, 2019, 34(3):47-50.